Norwest Closes $4 Billion Fund 18, Its Largest Ever

TL;DR
Norwest Venture Partners has closed Norwest 18 at $4 billion, the largest fund in the firm's 65-year history and a roughly one-third step-up from the $3 billion Norwest 17 closed in April 2024. The close pushes Norwest's total assets under management to $18 billion and funds the same global, multi-stage strategy the firm has run since 1961: venture and growth equity across technology, healthcare, and consumer, concentrated in the US, India, and Israel. Since Norwest 17 closed, the firm says it has made more than 85 new investments and backed over 30 liquidity events, including five IPOs and six strategic acquisitions. The fund is led by Jeff Crowe (Senior Managing Partner) and Jon Kossow (Managing Partner), and the firm is using the close to expand its operator-support platform with two new programs, Norwest Operator Collective and Norwest Kinetic.
Key Takeaways
Biggest fund in six and a half decades of history. Norwest 18's $4 billion close is the largest single fund the firm has raised since it was founded in 1961, surpassing Norwest 17's $3 billion (closed April 2024) by roughly a third and taking firm-wide AUM to $18 billion.
It is one fund, not an early-stage vehicle. Unlike most of the funds covered on this blog, Norwest 18 is not a single-stage venture fund. It is capital for Norwest's existing multi-stage model, deployed across venture and growth equity, from early rounds through late-stage growth checks, inside one vehicle rather than through separate funds by stage.
Three-geography focus, not a scattershot global mandate. Norwest is explicit that the fund targets the US, India, and Israel specifically, markets where the firm says it has built a 20-year track record, rather than a broad "global" claim with no real regional depth behind it.
Five named thesis areas anchor where the capital is already moving. The firm points to next-generation financial infrastructure, AI systems and agents, agentic-era cybersecurity, technology-enabled industrial and aerospace, and healthcare AI as the categories where it has been concentrating new checks, each with multiple named portfolio companies already in place.
Fund Overview
Fund Name: Norwest 18
Fund Size: $4 billion (firm-wide AUM now $18 billion)
Stage: Multi-stage - early-stage venture through growth equity, in one vehicle
Check Size: Not disclosed; historical range spans seed-stage venture checks to large growth-equity investments
Geography: United States, India, and Israel
Focus: Technology, healthcare, and consumer, with named emphasis on financial infrastructure, AI systems and agents, agentic-era cybersecurity, industrial and aerospace technology, and healthcare AI
Key LPs: Not disclosed
Why This Fund Matters
Scale and age are the real story here, and they're both unusually verifiable for a venture fund announcement. Norwest was founded in 1961, which puts Norwest 18 in a very small club of funds raised by firms with a continuous six-decade-plus operating history. A $4 billion close, one-third larger than the fund the firm raised just two and a half years ago, is also a real signal about LP demand at a moment when plenty of funds in the asset class have struggled to hit even flat re-ups. Firms don't grow a single fund by a third unless committed capital wants in.
The multi-stage structure is worth sitting with rather than skimming past. Most of the funds covered on this blog are purpose-built for one stage: a $27.5 million debut fund writing first checks into life sciences AI, or a $100 million fund targeting early B2B SaaS. Norwest 18 is capital for a firm that already runs venture and growth equity side by side, which means the same fund can lead a Series A and also write a large late-stage growth check into a company it backed a decade earlier. That's a structural advantage in follow-on situations, since the firm doesn't need to raise a separate growth vehicle or bring in new investors to keep participating as a portfolio company matures.
The geographic focus on the US, India, and Israel specifically (rather than a vague "global" mandate) is also meaningfully different from how most new funds position themselves. Norwest is claiming a specific 20-year track record in India and Israel, not a first-time expansion into those markets, and the fund's named portfolio companies back that up: OfBusiness (India), Swiggy (India, now listed as NSE:SWIGGY), and a roster of Israel-based security and infrastructure startups all point to genuine, long-running local networks rather than a fund manager parachuting into new geographies because the headlines say that's where the capital is going.
The liquidity numbers are the part that deserves the most scrutiny, and also the part that's most favorable to the firm if accurate. More than 30 liquidity events since April 2024, including five IPOs (Amagi Media Labs, BillionToOne, MBX Biosciences, Omada Health, and Swiggy) and six strategic acquisitions (Avetta by EQT, AbsenceSoft by Luminate Capital Partners, Ouro Medicines by Gilead Sciences, Qualified by Salesforce, tvScientific by Pinterest, and Veza by ServiceNow), is a genuinely strong exit cadence for a roughly two-and-a-half-year window, especially in a market where IPO windows have been inconsistent. These are self-reported figures from the firm's own announcement rather than independently audited, so treat the headline count as directionally accurate rather than certified, but the acquirer names are specific and checkable, which gives the claim more weight than a typical unverifiable "strong track record" line.
The Team
Norwest 18 is publicly led by Jeff Crowe, the firm's Senior Managing Partner, and Jon Kossow, Managing Partner, both of whom are quoted in the fund's announcement materials discussing the firm's growth and the rationale for the expanded fund size. Crowe frames the raise around the firm's long-term discipline and the depth of its platform for founders, while Kossow emphasizes the breadth of sectors and stages the fund can now address in a single vehicle. Neither executive's direct quotes are reproduced verbatim here; this is a paraphrase of the positioning in Norwest's own materials, not a transcript.
Early Portfolio
"Early portfolio" is a slight misnomer for a firm 65 years into its life, but the fund's recent deal activity is the most useful lens on where the new $4 billion is actually going. Norwest's own blog post cites more than 85 new companies backed since Norwest 17 closed in April 2024, while the firm's formal press release states more than 87 investments over the same period; the discrepancy is small and likely reflects a difference between "new companies" and "investments" (the latter can include follow-on checks into existing portfolio companies counted separately from first-time backs), but it's worth flagging rather than picking one number and presenting it as the single settled figure.
Within that activity, Norwest names specific companies across its five highlighted thesis areas. In next-generation financial infrastructure: Beltic, Rain, and Stablecore. In AI systems and agents: Coval, Generalist AI, and LlamaIndex. In agentic-era cybersecurity: Above Security, ORION Security, Red Access, and Zenity. In technology-enabled industrial and aerospace: East Range Group, Padmini VNA, JJG Aerospace, and Raghu Vamsi Aerospace Group. In healthcare AI: Infinx, Matchpoint Therapeutics, Rezo Therapeutics, Tokaido Health, and Vitalize Care. Alongside these newer bets, the firm continues to point to longer-tenured, higher-profile portfolio companies as proof points of its model, including Vuori (where Norwest says it was the first institutional investor, in a brand now valued near $5.5 billion), Gong, VAST Data, YipitData, Babylist, Monogram Health, and OfBusiness.
What This Means for Founders
If you're building in financial infrastructure, AI agents and tooling, agentic-era security, industrial or aerospace technology, or healthcare AI, and you're in the US, India, or Israel, Norwest just told the market exactly where it intends to spend a meaningful chunk of a $4 billion fund over the next several years. That specificity is useful: it's a much better targeting signal than a generic "we invest across technology" line, and the named companies in each category give you real comparables to reference when you're sizing up whether your deal fits the firm's current thesis.
The multi-stage structure also matters practically for how you think about this as a long-term relationship rather than a single check. A firm that can lead your Series A and also write the growth-stage check three or four rounds later, from the same fund family, is a different kind of partner than a seed fund that structurally cannot follow you past Series B. If you're raising early money from Norwest, it's worth asking directly how the firm thinks about follow-on reserves and whether the growth team gets involved before a later round, rather than assuming continuity.
Be appropriately skeptical of the firm's own framing of "largest fund in firm history" and the liquidity-event count as marketing points rather than settled facts. They appear to be accurate based on named, checkable acquirers and a verifiable step-up from the $3 billion Norwest 17, but they are self-reported, and founders should always independently verify a fund's actual check-writing behavior and reference portfolio companies directly rather than relying on a press release's own characterization of its track record.
Fund Momentum Take
This is a genuinely strong fund close, and the signal is more interesting than the headline number. A one-third step-up on a prior fund, at a firm old enough to have survived multiple full market cycles, says something real about institutional LP confidence in Norwest's model specifically, not just in venture as an asset class broadly; LPs re-upping bigger in this market are making an active bet, not a passive renewal.
The part I'd push back on slightly is the breadth of the thesis. Five distinct named categories (fintech infrastructure, AI agents, agentic security, industrial/aerospace, and healthcare AI) inside one $4 billion fund is a lot of surface area for a single vehicle to cover with real depth in each, even for a firm with Norwest's scale and tenure. That's not necessarily a flaw; a multi-stage, multi-sector fund of this size is supposed to look diversified. But founders in any one of those five categories should ask pointed questions about how much of the team's actual attention and follow-on capital is earmarked for their specific category versus the other four, rather than assuming "Norwest is active in healthcare AI" means the firm has deep, dedicated bandwidth there the way a single-sector specialist fund would.
The launch of Norwest Operator Collective and Norwest Kinetic alongside the fund close is also worth watching rather than taking at face value as a differentiator. Nearly every large, mature VC firm has been racing to stand up "AI-focused operator" and "advisor network" programs over the past two years, and the real test is usage and outcomes, not the existence of the program. If you're evaluating Norwest partly on the strength of its platform support, ask current portfolio founders how often they've actually used these specific resources, not just whether the firm says they exist.
Frequently Asked Questions
How big is Norwest 18, and how does it compare to the firm's prior fund?
Norwest 18 closed at $4 billion, making it the largest fund in Norwest Venture Partners' 65-year history. That's roughly a one-third increase over Norwest 17, which closed at $3 billion in April 2024, and it brings the firm's total assets under management to $18 billion.
What stages and sectors does Norwest 18 invest in?
The fund is multi-stage, covering both venture and growth equity from early rounds through late-stage growth checks, inside a single vehicle. Sector focus spans technology, healthcare, and consumer, with the firm naming five specific thesis areas it has been actively deploying into: next-generation financial infrastructure, AI systems and agents, agentic-era cybersecurity, technology-enabled industrial and aerospace, and healthcare AI.
Which geographies does the fund target?
Norwest is explicit about targeting the United States, India, and Israel, citing a 20-year track record of investing in India and Israel specifically, rather than claiming a broad, undifferentiated global mandate.
What has Norwest's portfolio activity looked like since its last fund closed?
The firm says it has made more than 85 new investments (its own blog post's figure; the formal press release cites more than 87 investments, a small discrepancy likely reflecting how follow-on checks are counted) and backed over 30 liquidity events since Norwest 17 closed in April 2024, including five IPOs (Amagi Media Labs, BillionToOne, MBX Biosciences, Omada Health, and Swiggy) and six strategic acquisitions (Avetta, AbsenceSoft, Ouro Medicines, Qualified, tvScientific, and Veza).
Who leads Norwest 18, and is the firm adding new founder-support programs with this close?
The fund is publicly led by Jeff Crowe, Senior Managing Partner, and Jon Kossow, Managing Partner. Alongside the close, Norwest is expanding its Portfolio Success platform, including doubling its Senior Advisor Network, adding new Operating Executives, and launching two new programs, Norwest Operator Collective and Norwest Kinetic, the latter focused on AI-specific operator support.
Raising a fund and want it covered here? Submit your fund.
Need help getting in front of the right LPs? Talk to our fundraising advisory team.
Related funds in the index
Active funds from the verified index
| Fund | Size | Stage | Location | Focus |
|---|---|---|---|---|
| Starfire Ventures | Targeting $200 million USD | Seed | United States | Wellness & Lifestyle, FemTech +2 |
| Plural Fund III | €1 billion combined, with roughly two-thirds allocated to new early-stage investments EUR | Pre Seed | United Kingdom | Defense, EnergyTech +3 |
| Sofinnova Crossover Fund II | €725 million EUR | Series C | France | Biotech, MedTech +1 |
| Sinew Impact Fund | CA$8 million at initial close, targeting CA$10 million USD | Seed | Global | |
| The 81 Collection Fund II | $82M USD | Growth | United States | Manufacturing, Supply Chain |